FI842164A0 - Foerbaettrat foerfarande foer framstaellning av steroidestrar. - Google Patents

Foerbaettrat foerfarande foer framstaellning av steroidestrar.

Info

Publication number
FI842164A0
FI842164A0 FI842164A FI842164A FI842164A0 FI 842164 A0 FI842164 A0 FI 842164A0 FI 842164 A FI842164 A FI 842164A FI 842164 A FI842164 A FI 842164A FI 842164 A0 FI842164 A0 FI 842164A0
Authority
FI
Finland
Prior art keywords
steroidestrar
foerfarande foer
foer framstaellning
foerbaettrat
foerbaettrat foerfarande
Prior art date
Application number
FI842164A
Other languages
English (en)
Other versions
FI80710B (fi
FI80710C (fi
FI842164A (fi
Inventor
Anders Robert Stamvik
Sten Krister Kristensson
Karl-Erik Lundvall
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of FI842164A0 publication Critical patent/FI842164A0/fi
Publication of FI842164A publication Critical patent/FI842164A/fi
Publication of FI80710B publication Critical patent/FI80710B/fi
Application granted granted Critical
Publication of FI80710C publication Critical patent/FI80710C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Amplifiers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
FI842164A 1983-05-30 1984-05-30 Foerbaettrat foerfarande foer framstaellning av steroidestrar. FI80710C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8303031A SE8303031D0 (sv) 1983-05-30 1983-05-30 Improved steroid esters preparation
SE8303031 1983-05-30

Publications (4)

Publication Number Publication Date
FI842164A0 true FI842164A0 (fi) 1984-05-30
FI842164A FI842164A (fi) 1984-12-01
FI80710B FI80710B (fi) 1990-03-30
FI80710C FI80710C (fi) 1990-07-10

Family

ID=20351375

Family Applications (1)

Application Number Title Priority Date Filing Date
FI842164A FI80710C (fi) 1983-05-30 1984-05-30 Foerbaettrat foerfarande foer framstaellning av steroidestrar.

Country Status (18)

Country Link
US (1) US4537722A (fi)
EP (1) EP0127829B1 (fi)
JP (1) JPS6041696A (fi)
AT (1) ATE32603T1 (fi)
AU (1) AU560235B2 (fi)
CA (1) CA1211430A (fi)
DE (1) DE3469440D1 (fi)
DK (1) DK162100C (fi)
ES (1) ES8503008A1 (fi)
FI (1) FI80710C (fi)
GR (1) GR82048B (fi)
HU (1) HU198217B (fi)
IE (1) IE57425B1 (fi)
IL (1) IL71870A (fi)
NZ (1) NZ208174A (fi)
PT (1) PT78661B (fi)
SE (1) SE8303031D0 (fi)
ZA (1) ZA843946B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
CN1100541C (zh) * 1993-01-19 2003-02-05 恩多研究公司 脱氢表雄酮的治疗用途和传送系统
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5892068A (en) * 1998-08-25 1999-04-06 Mcneil-Ppc, Inc. Preparation of sterol and stanol-esters
US6087522A (en) * 1999-10-12 2000-07-11 Fan Tech Corporation Silicone lanolin esters
WO2005070951A1 (en) * 2004-01-16 2005-08-04 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
MY150972A (en) * 2008-11-10 2014-03-31 Bridgestone Corp Modified natural rubber, production process for the same and rubber composition and tire prepared by using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050883A (fi) *
DE1958954C3 (de) * 1969-11-24 1978-11-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Veresterung von Alkoholen
US3678082A (en) * 1970-07-30 1972-07-18 Searle & Co Esterification of 17-hydroxy steroids
GB1558472A (en) * 1976-01-22 1980-01-03 Leo Ab 17-esters of 17- hydroxy gestogens
GB1565680A (en) * 1976-12-31 1980-04-23 Leo Ab Method for the preparation of carboxylic acid esters

Also Published As

Publication number Publication date
JPH0369360B2 (fi) 1991-10-31
SE8303031D0 (sv) 1983-05-30
PT78661A (en) 1984-06-01
HUT34222A (en) 1985-02-28
EP0127829A2 (en) 1984-12-12
IE57425B1 (en) 1992-09-09
DK265484D0 (da) 1984-05-29
AU560235B2 (en) 1987-04-02
US4537722A (en) 1985-08-27
DK265484A (da) 1984-12-01
PT78661B (en) 1986-06-26
EP0127829B1 (en) 1988-02-24
NZ208174A (en) 1987-04-30
ATE32603T1 (de) 1988-03-15
ES532905A0 (es) 1985-02-01
DK162100C (da) 1992-02-24
AU2883284A (en) 1984-12-06
ZA843946B (en) 1984-12-24
IE841192L (en) 1984-11-30
FI80710B (fi) 1990-03-30
DE3469440D1 (en) 1988-03-31
CA1211430A (en) 1986-09-16
FI80710C (fi) 1990-07-10
IL71870A0 (en) 1984-09-30
IL71870A (en) 1986-10-31
FI842164A (fi) 1984-12-01
DK162100B (da) 1991-09-16
GR82048B (fi) 1984-12-12
HU198217B (en) 1989-08-28
EP0127829A3 (en) 1985-08-07
ES8503008A1 (es) 1985-02-01
JPS6041696A (ja) 1985-03-05

Similar Documents

Publication Publication Date Title
DE69432109D1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
ATE54154T1 (de) Retro-inverse analoga des bradykininpotentialisierenden peptids bpp-5a und verfahren zu ihrer herstellung.
TR200001079T2 (tr) Bisiklik kinaz inhibitörleri.
ATE216360T1 (de) Sulfinsäurederivate und deren herstellung und verwendung
TR200100299T2 (tr) Tedavi edici biaril türevleri.
NZ208529A (en) 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions
FI842164A0 (fi) Foerbaettrat foerfarande foer framstaellning av steroidestrar.
DK0544826T3 (da) Overlegne trombomodulinanaloger til farmaceutisk anvendelse
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
TR200101083T2 (tr) (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.
UA15920A (uk) Аміди циклометілеh-1, 2-дикарбоhових кислот, які мають гіпотеhзивhу активhість
SE7714032L (sv) Forbettrat forfarande for framstellning av estrar
ATE256664T1 (de) Herstellung von (s)-decahydroisochinolin-3- carbonsäure-t-butylamid
DE60042273D1 (de) Antitumorantikörper, proteine und deren verwendung
ES8505351A1 (es) Un procedimiento para preparar nuevas aroilimidazolonas
ATE46692T1 (de) (6,11-dihydro-11-oxodibenz(b,e>oxepinyl)pentaans|uren und derivate, verfahren und zwischenprodukte zu deren herstellung und deren verwendung als arzneimittel.
IE41485L (en) Purification of protein conjugates
ATE28892T1 (de) Verwendung von salicylsaeureestern als riechstoffe, diese enthaltende riechstoffkompositionen, sowie neue salicylsaeureester.
ATE17718T1 (de) Aza-analoge von aminosaeure-derivaten und ihre verwendung als antihypertensive.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: PHARMACIA AB

MA Patent expired

Owner name: PHARMACIA & UPJOHN AB